SH0.F · Shionogi & Co., Ltd

-

Please sign in to comment on SH0.F

1 Comment

Admin

4 years, 6 months ago

Shionogi & Co., Ltd is currently in a long term uptrend where the price is trading 15.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.9.

Shionogi & Co., Ltd's total revenue sank by 18.0% to $76B since the same quarter in the previous year.

Its net income has dropped by 6.5% to $37B since the same quarter in the previous year.

Finally, its free cash flow fell by 53.2% to $5B since the same quarter in the previous year.

Based on the above factors, Shionogi & Co., Ltd gets an overall score of 2/5.

Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	F
CurrencyCode	EUR
ISIN	JP3347200002

Target Price	None
Dividend Yield	2.9%
Beta	0.13
Market Cap	12B
PE Ratio	11.49

ABOUT

Shionogi & Co., Ltd

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

SH0.F · Shionogi & Co., Ltd

-

Shionogi & Co., Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Shionogi & Co., Ltd using a moving average strategy